Non‐Pore Dependent and MMP‐9 Responsive Gelatin/Silk Fibroin Composite Microparticles as Universal Delivery Platform for Inhaled Treatment of Lung Cancer
Advanced Materials · 2023-10 · 35 (42)
DOI: 10.1002/adma.202303718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 20.09.2023. Verfasst von Shuangquan Gou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key laboratory of Biorheological Science and Technology, Ministry of Educations, Collage of Bioengineering, Chongqing University, Chongqing, 40044, C…. Hauptthemen laut MEDLINE: Fibroins, Lung Neoplasms. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of Chia, Natural Science Foundation of Chongqing, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Developing a drug delivery platform that possesses universal drug loading capacity to meet various requirements of cancer treatment is a challenging yet interesting task. Herein, a self‐assembled gelatin/silk fibroin composite (GSC) particle based drug delivery system is developed via microphase separation followed by desolvation process. Thanks to its preassembled microphase stage, this GSC system is suitable for varying types of drugs. The desolvation process fix drugs inside GSC rapidly and densify the GSC structure, thereby achieving efficient drug loading and providing comprehensive protection for loaded drugs. Actually, the size of this brand‐new non‐pore dependent drug delivery system can be easily adjusted from 100 nm to 20 µm to fit different scenarios. This work selects GSC with 3 µm diameter as the universal inhaled drug delivery platform, which shows an excellent transmucosal penetration and lung retention ability. Additionally, the MMP‐9 sensitive degradation property of GSC enhances the targeted efficiency of drugs and reduces side effects. Intestinally, GSC can self‐amplify the regulation of innate immunity to reverse the cancerous microenvironment into an antitumor niche, significantly improving the therapeutic effect of drugs. This study of GSC universal drug platform provides a new direction to develop the next‐generation of drug delivery system for lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key laboratory of Biorheological Science and Technology, Ministry of Educations, Collage of Bioengineering, Chongqing University, Chongqing, 40044, China.
- Department of Orthopedic, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 200080, Shanghai, China.
ORCID-Profile: Qian Feng, Kaiyong Cai
Förderung
- National Natural Science Foundation of Chia
- Natural Science Foundation of Chongqing
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Gou, S., Wang, G., Zou, Y., Geng, W., He, T., Qin, Z., Che, L., Feng, Q., & Cai, K. (2023). Non‐Pore Dependent and MMP‐9 Responsive Gelatin/Silk Fibroin Composite Microparticles as Universal Delivery Platform for Inhaled Treatment of Lung Cancer. Advanced Materials, 35(42). https://doi.org/10.1002/adma.202303718
Vancouver
Gou S, Wang G, Zou Y, Geng W, He T, Qin Z, et al. Non‐Pore Dependent and MMP‐9 Responsive Gelatin/Silk Fibroin Composite Microparticles as Universal Delivery Platform for Inhaled Treatment of Lung Cancer. Advanced Materials. 2023;35(42). doi:10.1002/adma.202303718
BibTeX
@article{Gou2023,
author = {Gou, Shuangquan and Wang, Gangyang and Zou, Yanan and Geng, Wenbo and He, Tingting and Qin, Zizhen and Che, Lingbin and Feng, Qian and Cai, Kaiyong},
title = {Non‐Pore Dependent and MMP‐9 Responsive Gelatin/Silk Fibroin Composite Microparticles as Universal Delivery Platform for Inhaled Treatment of Lung Cancer},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {42},
doi = {10.1002/adma.202303718}
}
EUVIMED